Reference: Chetty, S. (2021). Dr Chetty’s 8th day therapy for COVID-19. Covexit. Retrieved from [URL] Summary: Dr Shankara Chetty’s 8th Day Therapy for COVID-19 addresses the inflammatory phase occurring after Day 8 of infection, aiming to prevent severe disease progression. The document outlines four key interventions starting at this critical juncture. First, corticosteroids like Prednisone […]
Reference: FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/ Summary: The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin
Reference: Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., … & Madhi, S. A. (2021). Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. The New England Journal of Medicine, 384(20), 1899-1909. https://doi.org/10.1056/NEJMoa2103055 Summary: The NVX-CoV2373 nanoparticle vaccine was evaluated in a phase 2 trial in South Africa during the B.1.351
Reference: Mair, V. (2021, April 30). Merriam-Webster gives “vaccine” a new definition. Language Log. Retrieved from https://languagelog.ldc.upenn.edu/nll/?p=50886 Summary: In a recent post, Victor Mair discusses an update to the definition of “vaccine” by Merriam-Webster. While traditional definitions describe vaccines as preparations of weakened or killed pathogens, the new entry expands this definition significantly. It now
Reference: South African Medical Research Council. (2021). Sisonke Protocol Version 4.4 dated 29 Apr 2021. Summary: The Sisonke Protocol is an open-label, single-arm phase 3B study aimed at evaluating the effectiveness of the Ad26.COV2.S COVID-19 vaccine among healthcare workers in South Africa. This study involves approximately 500,000 healthcare workers aged 18 and older, who will
Reference: Livingston, E. H., Malani, P. N., & Creech, C. B. (2021). The Johnson & Johnson vaccine for COVID-19. JAMA Patient Page. https://doi.org/10.1001/jama.2021.2927 Summary: The Johnson & Johnson COVID-19 vaccine employs a unique approach using a modified adenovirus to induce an immune response without causing infection. Unlike mRNA vaccines from Pfizer and Moderna, which require
Reference: VigiAccess. (2021). VigiAccess™. Retrieved from https://who-umc.org Summary: VigiAccess provides a comprehensive overview of adverse drug reactions (ADRs) associated with Covid-19 vaccines, highlighting a total of 2,183,912 reports. The data illustrates the geographical distribution of ADRs, with significant counts reported across continents such as the Americas, Europe, and Asia. The analysis categorises ADRs into various
Reference: The NewERA. (2021, April 8). SAHPRA destroyed in court – Ivermectin available. Summary: On 8 April 2021, a significant court ruling declared that the South African Health Products Regulatory Authority (SAHPRA) could no longer restrict access to Ivermectin, a treatment believed to help with HIV and COVID-19. The High Court found SAHPRA’s actions to
Reference: Taniokal, H., Taniokal, S., & Kaga, K. (2021). Why COVID-19 is not so spread in Africa: How does Ivermectin affect it? medRxiv. https://doi.org/10.1101/2021.03.26.21254377 Summary: This article explores the low incidence of COVID-19 in Africa, investigating the potential effects of ivermectin, a treatment for onchocerciasis, on morbidity and mortality rates. A statistical analysis was conducted
Reference: Nakagami, H. (2021). Development of COVID-19 vaccines utilizing gene therapy technology. International Immunology, 33(10), 521–527. https://doi.org/10.1093/intimm/dxab013 Summary: The article discusses the urgent development of COVID-19 vaccines in response to the SARS-CoV-2 outbreak. Various vaccine technologies are being explored, categorised into four main groups: intact target viruses, proteins, viral vectors, and nucleic acids. RNA and